Skip to content

TRENDING

Study finds ropeginterferon alfa-2b is ‘superior’ 2nd-line treatment for essential thrombocythemia

Join SOHO

Follow Us :

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Cellular Therapy

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Leukemia

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Lymphoma

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Multiple Myeloma

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Myelodysplastic Syndromes

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Myeloproliferative Neoplasms

Contact Info

editor@SOHOInsider.com 1.281.364.7387

Follow Us

June 14, 2025

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Cellular Therapy

Cellular Therapy

Chimeric antigen receptor

Cellular Therapy Lymphoma

Armored CAR-T option shows promise in previously CAR-treated lymphoma

by SOHO Insider Editors
May 19, 2025
0 Comments

Cellular Therapy 2025 AACR Annual Meeting Multiple Myeloma

Trispecific therapy ISB 2001 active in ongoing early myeloma trial

by Leah Sherwood
April 29, 2025
0 Comments

Cellular therapy

Cellular Therapy

Early-phase study shows promise of novel CAR-T talicabtagene autoleucel for B-cell malignancies

by SOHO Insider Editors
April 11, 2025
0 Comments

Cellular Therapy Lymphoma News

Machine learning identifies inflammatory biomarker that predicts CAR-T response in lymphoma patients

by Leah Sherwood
April 3, 2025
0 Comments

Apheresis machine to extract plasma and platelet from whole blood

Cellular Therapy Lymphoma News

Risk factors for manufacturing failure, associated outcomes in patients receiving CAR-T for LBCL

by SOHO Insider Editors
March 18, 2025
0 Comments

Fried salmon steak with vegetables on wooden table

Cellular Therapy News

How do lifestyle factors play a role in the response to CAR-T therapy?

by Leah Sherwood
March 13, 2025
0 Comments

Chimeric antigen therapy

Cellular Therapy Multiple Myeloma

Patient case highlights secondary tumor after CAR-T treatment for myeloma

by SOHO Insider Editors
March 12, 2025
0 Comments

Megan Melody, MD

Cellular Therapy Lymphoma News Society Updates Young Investigator Program

SOHO Young Investigator Spotlight: Meet Megan Melody, MD

by Leah Sherwood
March 7, 2025
0 Comments

cancer cell

Cellular Therapy Lymphoma

CAR-NK cell therapy FT596 ‘well tolerated’ in phase 1 trial

by Leah Sherwood
January 16, 2025
0 Comments

older adult patient

Cellular Therapy Multiple Myeloma News

Do older patients with myeloma respond as well to ide-cel as younger patients?

by Leah Sherwood
January 14, 2025
0 Comments

1
2

Top Categories

Cellular Therapy

12

Leukemia

41

Lymphoma

38

Multiple Myeloma

28

Myelodysplastic Syndromes

13

Myeloproliferative Neoplasms

9

POPULAR NEWS

Leukemia , Lymphoma , Multiple Myeloma , Myelodysplastic Syndromes , Myeloproliferative Neoplasms , News , Society Updates

Abstract submissions now open for SOHO 2025

February 14, 2025

MyeloMatch, NCI

Leukemia , Acute Myeloid Leukemia , Myelodysplastic Syndromes

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

January 3, 2025

Imatinib

66th American Society of Hematology Annual Meeting & Exposition , Leukemia

Asciminib benefit-risk profile bests other TKIs in CML

December 10, 2024

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Categories

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Cellular Therapy

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Leukemia

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Lymphoma

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Multiple Myeloma

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Myelodysplastic Syndromes

Armored CAR-T option shows promise in previously CAR-treated lymphoma

Myeloproliferative Neoplasms

Subscribe

Recent Posts

options

Study finds ropeginterferon alfa-2b is ‘superior’ 2nd-line treatment for essential thrombocythemia

Molecular structure of cancer cells under microscope, realistic macro indoor part of body.

Longer-term follow-up demonstrates efficacy of nemtabrutinib for refractory FL

EHA 2025

Dr. Kuykendall from EHA 2025: ‘the research is as hot as the conference center’

Copyright © 2025 Society of Hematologic Oncology, All rights reserved.